ESC Premium Access

Management of care in atrial fibrillation patients: impact of following guidelines for treatment of atrial fibrillation and comorbid conditions

Topic: Stroke Prevention
Sponsored by Thrombosis Research Institute

Congress Session

About the speaker

Professor John Camm

St George's University of London, London (United Kingdom of Great Britain & Northern Ireland)
56 presentations
1 follower

6 more presentations in this session

What have registries taught us? New insights from GARFIELD-AF

Speaker: Professor A. Kakkar (London, GB)

Thumbnail

Long-term outcomes

Speaker: Professor D. Atar (Oslo, NO)

Thumbnail

Innovations in risk assessment: an integrated risk tool for stroke, death and bleeding

Speaker: Professor K. Fox (Edinburgh, GB)

Thumbnail

Changes in antithrombotic therapy after atrial fibrillation diagnosis

Speaker: Doctor F. Cools (Brasschaat, BE)

Thumbnail

Three-way comparison of effectiveness among different classes of oral anticoagulants: GARFIELD-AF study

Speaker: Professor S. Goto (Isehara, JP)

Thumbnail

Access the full session

What is the long term impact of atrial fibrillation? Insights from GARFIELD-AF

Speakers: Professor J. Camm, Professor A. Kakkar, Professor D. Atar, Professor K. Fox, Doctor F. Cools...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Related content

ESC Premium Access

The Day in Focus - Monday 30 August - Panel.

30 August 2021

ESC Premium Access

STOPDAPT-2 ACS - Panel discussion.

30 August 2021

ESC Premium Access

STOPDAPT-2 ACS - Discussant review.

30 August 2021

This platform is supported by

logo Novo Nordisk